Introduction
The lysosomal storage disease GM1-gangliosidosis is caused by an autosomal recessive deficiency of lysosomal acid b-galactosidase (bgal). 1 The disease affects many organs, including the central nervous system (CNS). There, deficiency of bgal results in the accumulation of the ganglioside GM1 and its asialo derivative GA1, which causes progressive neurodegeneration. 2 Recently, direct gene delivery to the CNS by adenoassociated viral (AAV) vectors has emerged as a strategy to engineer an in situ source of lysosomal enzyme for several neuronopathic lysosomal storage diseases. 3 This has been possible because lysosomal enzymes can be secreted at high levels by genetically modified cells in the brain, and subsequently taken up by enzyme-deficient cells through receptor-mediated endocytosis resulting in the correction of lysosomal storage in large regions of the murine CNS. [4] [5] [6] [7] [8] [9] Translation of these findings to clinical trials will require careful consideration of routes of administration and target structures from where metabolically active enzymes can be produced, released and distributed throughout the CNS. Thus it is of paramount importance to understand the mechanisms by which these enzymes can be distributed in the brain. In addition to diffusion in the brain parenchyma, 10, 11 it has been shown that at least two of these enzymes, b-glucuronidase and arylsulfatase A, can be transported by axonal transport within neurons from the site of production. [12] [13] [14] Moreover, CSF flow has been shown to contribute to the distribution of both b-glucuronidase, a-L-iduronidase and tripeptidyl peptidase 1 throughout the CNS. 11, 15, 16 Given our continued interest in developing an AAVmediated gene therapy approach to treat GM1-gangliosidosis, we set out to investigate whether the mechanisms of distribution earlier described for GUSB, Arylsulfatase A and tripeptidyl peptidase 1 are also functional for bgal. This has obvious implications for choosing target structures to be engineered by AAVmediated gene delivery to achieve global distribution of enzymes in the brain with the minimum number of injections possible. The hippocampus has been previously used to map the distribution of lysosomal enzymes by axonal transport 12, 14 because its circuitry is well characterized. Therefore, we characterized the distribution of bgal in adult GM1-gangliosidosis mouse brain after AAV-mediated gene delivery to the hippocampus. To this aim, we injected 1 ml of AAV2/1-CBA-MBG-W vector [4.1 Â 10 10 g.c. (genome copies)] 17 into the left hippocampus of 6-week-old GM1-gangliosidosis mice. 18 One month postinjection, we observed mouse bgal in physically and synaptically connected areas consistent with three main mechanisms of lysosomal enzyme distribution in the brain.
Diffusion of bgal
Upon injection of AAV vector into the hippocampus, the overlaying cerebral cortex was stained in a pattern that appears to radiate from the hippocampus (Figures 1a  and b) . Staining in the cortex expands from a region spanning the retrosplenial cortex to the primary somatosensory cortex barrel field in rostral sections ( Figure 1a3 ) to a region spanning the retrosplenial cortex to the temporal association cortex in caudal sections (Figure 1a5 ). This expanding staining pattern seems to mirror the progression of the hippocampal formation from a medial position in rostral sections ( Figure 1a2 ) to a medial lateral position in caudal sections ( Figure 1a5 ). As in situ hybridization for vector-associated mRNA showed no signal in bgal-positive cortical regions except the entorhinal cortex (arrowheads in Figures 2c and d) , we conclude that bgal activity in cortex is mostly the result of diffusion, a mechanism shown to be involved in the distribution of several other lysosomal enzymes. 11, 20 The significance of vector mRNA in the entorhinal cortex will be addressed below.
Retrograde axonal transport within neurons from the site of production
The contralateral hippocampal region was strongly positive for bgal, with the highest activity (darkest stain) associated with the CA3 pyramidal cell layer (Figure 1a4 , arrow in Figure 1e ). This is consistent with retrograde axonal transport along the commissural collaterals that project from this region to the oriens and radiatum layers in the injected hippocampus. 21, 22 This notion is supported by the fact that the ventral hippocampal commissure was intensely stained (gray arrow in Figure 1 Histochemical analysis of b-gal expression by X-gal staining upon hippocampal injection. One ml of AAV2/1-CBA-MBG-W vector stock (4.1 Â 10 10 g.c.) was infused at 0.1 ml min À1 into the left hippocampus (stereotactic coordinates from bregma: AP À2 mm, ML +1.5 mm, DV À2 mm) of 6-week-old GM1-gangliosidosis mice (n ¼ 5). Mice were killed at 1 month postinfusion and bgal distribution in the brain analyzed by X-gal staining as described. 17 Cells distant from the injection site (white arrow in a4) were enzyme-positive (a1-6). Staining indicative of the presence of the lysosomal enzyme was observed in the ipsilateral (b), and contralateral cortex (c), the entorhinal cortex (Ect) (d), the ipsilateral and contralateral hippocampus and DG (a3-5 and e), medial nucleus (MS) and both ipsilateral and contralateral dorsal lateral nuclei (LSD) of the septum (f), perivascular space (arrow in g), mammillary body (MB) (h) and leptomeninges (arrow in i). Scale bars in (a) represent 1 mm. Magnification (b-i): Â 40.
Mechanisms of distribution of mouse b-galactosidase
MLD Broekman et al Figure 1a2 ). In the rest of the contralateral hippocampus, most bgal activity is associated with the oriens and radiatum layers of CA1-CA2, and not the pyramidal cell layer per se ( Figure 1e ). This pattern of enzyme distribution is consistent with anterograde transport of bgal along commissural collaterals from the AAV-injected CA3 region, or Schaffer collaterals from the non-injected CA3 pyramidal cell layer. Moreover, the fact that bgal appears to diffuse to the contralateral overlaying cortex in a radial gradient emanating from the hippocampus (Figures 1a3-a4 and c) suggests that enzyme transported in this manner can be released at the axonal terminals. Also the pattern of bgal distribution in the medial and dorsolateral septal nuclei (Figure 1f ) suggests that anterograde transport of bgal is an important component of its axonal transport. Most bgal staining in the septal area is associated with dorsolateral nuclei that receive projections from the CA3 pyramidal cell layer. 23, 24 Another example of axonal transport of bgal is the staining present in the mammillary nucleus (Figures 1a5  and h ). This nucleus receives afferents from and sends projections to the subicular region of the hippocampal formation that travels along the postcommissural fornix. 25, 26 Although most in vivo studies to date have indicated that lysosomal enzymes are retrogradely transported in axons, 12, 13, 27 our data strongly suggests that anterograde transport of bgal is an important component of axonal distribution of this enzyme in the adult GM1-gangliosidosis brain. This notion is supported by a recent study showing identical frequency of anterograde and retrograde movement of GFP-labeled a-L-iduronidase in neurites of primary rat neurons. 28 
CSF flow in perivascular space of Virchow-Robin
In addition to bgal distribution in the hippocampus, we observed strong staining of the leptomeninges and perivascular space in the brain (Figures 1g and i) . This suggests that a considerable amount of bgal is released from transduced cells into the interstitial space and is further distributed by CSF flow in the perivascular space of Virchow-Robin. An alternative explanation is that AAV vector transduced those bgal-positive regions, and the apparent absence of ISH signal in leptomeninges is because of low spatial resolution associated with the radioactive technique employed here. Presently, we are unable to exclude this possibility. However, the first interpretation is consistent with data available for b-glucuronidase, 11 a-L-iduronidase, 15 and tripeptidyl peptidase 16 and is likely the basis for the success in using intracerebroventricular (i.c.v.) 11 or intrathecal infusion 15 of AAV vectors or purified recombinant enzymes 16 in adult animals to achieve widespread correction of lysosomal storage in the brain. Previously we have shown i.c.v. infusion of AAV vectors in neonatal GM1-gangliosidosis mice is highly effective in correcting neurochemical pathology. 17 The effectiveness of this strategy in adult GM1-gangliosidosis mice is likely to depend on achieving efficient transduction of choroid plexus, ependymal cells and/or periventricular regions with a particular AAV serotype.
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Axonal transport of mRNA
We investigated the distribution of AAV-transduced cells in the hippocampus by in situ hybridization using a WPRE-specific antisense probe (Figures 2a-d) . In addition to a strong signal in the injected structure (ventral hippocampus), we found a considerable signal in the contralateral hippocampus (arrows in Figures 2b-d) , ipsilateral CA1 region (asterisks in Figures 2c and d) and ipsilateral entorhinal cortex (arrow head Figures 2c and d) . 
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No signal was present using antisense probe in uninjected GM1-KO brains or sense probe in AAV-injected GM1-KO brains. The signal in the contralateral hippocampus and ipsilateral CA1 region is consistent with mRNA presence in commissural and Schaffer collaterals, respectively, emanating from AAV-transduced CA3 pyramidal neurons. The intense signal in the ventral hippocampal commissure (arrow Figure 2a) supports the notion that vector-derived mRNA is present in commissural collaterals.
In the entorhinal cortex, stellate neurons in layer II send projections to the outer two-thirds of the molecular layer of the DG through the perforant pathway. 29, 30 As the entorhinal cortex in adult mice does not receive projections from the hippocampus, we postulate that the ISH signal observed in this structure (arrowhead in Figures 2c and d) is because of AAV vector transduction after retrograde transport along the perforant pathway, as reported earlier. 31 Transduction of the ipsilateral entorhinal cortex is consistent with the fact that this region presented the highest bgal staining intensity in the ipsilateral cortex (Figures 1a4-5 and 1d) .
Next we investigated whether the ISH signal in contralateral hippocampus was because of axonal mRNA 'transport' or the presence of AAV-transduced cells. We isolated DNA and RNA from laser capture microdissected ipsi-, and contralateral hippocampi and performed PCR on DNA and cDNA using WPREspecific primers. This analysis revealed the presence of AAV vector genomes and vector-derived mRNA in the ipsilateral hippocampus, but only vector-derived mRNA in the contralateral hippocampus (Figures 3a and b) . Spiking DNA samples with 500 pg of control plasmid showed that the absence of PCR amplification from the contralateral hippocampus was most likely because of the absence of AAV vector genomes and not the presence of a PCR inhibitor in the DNA preparations (Figure 3c ).
These results confirm our interpretation of the ISH results that vector-derived mRNA was distributed to projection fields of CA3 pyramidal neurons in the contralateral hippocampus. Luca et al. found similar results with apparent distribution of vector-encoded mRNA to axonally connected structures, but discounted it as background. 14 Axonal transport of specific mRNAs to growth cones is a highly regulated process involving RNA 'zip codes' and transporter proteins. 32 It is possible that the WPRE element present in the vectors used in both studies reporting axonal localization of mRNA, contains a cryptic or real axonal mRNA localization signal. At this point we do not have evidence suggesting a functional role for axonal vector mRNA in the distribution of lysosomal enzymes in the brain. It is unlikely for this mRNA to be translated into functional bgal in axonal terminals as lysosomal enzymes require endoplasmic reticulum translation, glycosylation and maturation in the Golgi compartment. To our knowledge none of these structures are present in axonal terminals, although there is evidence suggesting that polyribosomes are present in certain areas of axons, 33 and that translation takes place in growth cones. 32 
Correction of lysosomal storage in enzyme-positive regions
We have previously shown that lysosomal storage in GM1-gangliosidosis mouse brain is accompanied by cholesterol storage/trapping in the endosomal/ lysosomal compartment as revealed by Filipin staining of histological sections of the brain. 17 Thus, Filipin staining can be used as a surrogate marker of lysosomal storage in GM1 brain. To test whether bgal was effective in correcting lysosomal storage in distal sites, we analyzed the pattern of Filipin staining in the brains of both treated and untreated GM1-KO mice. Strong perikaryal staining, consistent with endosomal/lysosomal accumulation of cholesterol, was observed throughout the entire brain in untreated GM1-KO mice (Figure 4h ). In AAV1-mbgal treated bgalÀ/À mice we observed weak, diffuse Filipin staining in all enzymepositive regions of the brain as the cortex above both hippocampi (Figures 4a and b) , ipsilateral and contralateral hippocampi (Figures 4c and d) , and ipsilateral thalamus (Figure 4e ). In the contralateral thalamus (Figure 4f ), the ipsilateral striatum (Figure 4g ), contralateral striatum (data not shown) and other regions of the cortex (data not shown), there was no evidence of storage reduction. We conclude from this histological analysis of lysosomal storage that bgal present in distal sites is functional.
Here, we describe the mechanisms that contribute to distribution of lysosomal acid b-galactosidase in the GM1-gangliosidosis brain upon AAV-mediated delivery: diffusion, axonal transport and CSF flow. In addition, we found evidence of axonal transport of vector-encoded mRNA. These results will guide our selection of target structures and delivery modalities to achieve widespread distribution of bgal throughout the GM1-gangliosidosis central nervous system after AAV-mediated gene delivery. Figure 3 Vector mRNA not DNA present in contralateral hippocampus. Sections from two AAV2/1-CBA-MBG-W injected brains designated for LCM, were mounted on RNase-free, membrane slides (Molecular Machines and Industries-MMI, Glattbrugg, Switzerland), dried at room temperature and stored at À80 1C. Next, they were dried in serial ethanols and residual TBSfreezing media was removed. The sections were viewed under a Nikon TE2000 inverted microscope connected to CellCut LCM equipment (MMI). The ipsilateral and contralateral hipppocampi were identified and dissected (UVCut software package; MMI). The samples were picked up on adhesive lids of 500 ml mini IsolationCaps (MMI) and used for DNA and RNA extraction using PicoPure DNA and RNA isolation kits (Arcturus-Molecular Devices, Mountain View, CA, USA). RNA was subjected to an additional DNase digestion (Qiagen, Valencia, CA, USA), according to the manufacturer's instructions. DNA and RNA concentrations were determined using a NanoDrop ND-1000 Spectrophotometer (NanoDrop, Wilmington, DE, USA). cDNA was prepared using Omniscript reverse transcription kit (Qiagen). PCR on DNA (a), cDNA (b), and DNA spiked with 500 pg of plasmid control (c) for WPRE was performed in triplicate using the following primers: forward 5 0 -ATGTTGCTCCTTTTACGCTATGTGG-3 0 and reverse 5 0 -GAAAGC GAAAGTCCCGGAAAGG-3 0 . Samples: 1-Ipsilateral hippocampus; 2-water control; 3-Contralateral hippocampus; 4-Plasmid control.
Mechanisms of distribution of mouse b-galactosidase MLD Broekman et al Figure 4 Correction of storage in enzyme-positive areas. One series of sections representing the entire brain were stained with Filipin (Sigma, St Louis, MO, USA) and counterstained for nuclei with TO-PRO3 as described earlier. 17 Untreated bgalÀ/À mice showed strong perikaryal staining throughout the brain, consistent with endosomal/lysosomal accumulation of cholesterol as in the somatosensory cortex (h). As in normal mouse brain (not shown), weak diffuse Filipin staining was observed in the ipsilateral and contralateral cerebral cortex overlaying the hippocampus (a and b), the ipsi-and contralateral hippocampus (c and d) and the ipsi-and contralateral thalamus (e and f). Strong staining was detected in the contralateral thalamus (f), and both ipsi-(g) and contralateral (not shown) striatum. Scale bars represent 200 mm.
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